Lanean...
Study of binding interaction of rivaroxaban with bovine serum albumin using multi-spectroscopic and molecular docking approach
BACKGROUND: Rivaroxaban is a direct inhibitor of coagulation factor Xa and is used for venous thromboembolic disorders. The rivaroxaban interaction with BSA was studied to understand its PK and PD (pharmacokinetics and pharmacokinetics) properties. Multi-spectroscopic studies were used to study the...
Gorde:
| Argitaratua izan da: | Chem Cent J |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736510/ https://ncbi.nlm.nih.gov/pubmed/29260434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-017-0366-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|